Jorge Máspero

Researcher Next ID · RN-010361

Researcher · Medicine

, Argentina

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Social Sciences

Asthma and respiratory diseases

Allergic Rhinitis and Sensitization

IL-33, ST2, and ILC Pathways

Respiratory and Cough-Related Research

Delphi Technique in Research

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
The Lancet · 2019 · 10.1016/s0140-6736(19)31881-1
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
New England Journal of Medicine · 2018 · 10.1056/nejmoa1804092
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
New England Journal of Medicine · 2018 · 10.1056/nejmoa1804093
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
The Lancet · 2016 · 10.1016/s0140-6736(16)30307-5
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
The Lancet Respiratory Medicine · 2015 · 10.1016/s2213-2600(15)00042-9

No projects listed.